COVID-19 Impact on Global Targeted Drug BRAF Inhibitors for NSCLC Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-targeted-drug-braf-inhibitors-4-nsclc-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Targeted Drug BRAF Inhibitors for NSCLC status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Targeted Drug BRAF Inhibitors for NSCLC development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- BeiGene
- Novartis
- Dabrafenib
- Trametinib
- Lifirafenib
- Other
- Squamous Cell Carcinoma of NSCLC
- Adenocarcinoma of NSCLC
- Large Cell Carcinoma of NSCLC
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Targeted Drug BRAF Inhibitors for NSCLC status, future forecast, growth opportunity, key market and key players.
- To present the Targeted Drug BRAF Inhibitors for NSCLC development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Targeted Drug BRAF Inhibitors for NSCLC Revenue
1.4 Market Analysis by Type
1.4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Dabrafenib
1.4.3 Trametinib
1.4.4 Lifirafenib
1.4.5 Other
1.5 Market by Application
1.5.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application: 2020 VS 2026
1.5.2 Squamous Cell Carcinoma of NSCLC
1.5.3 Adenocarcinoma of NSCLC
1.5.4 Large Cell Carcinoma of NSCLC
1.6 Coronavirus Disease 2019 (Covid-19): Targeted Drug BRAF Inhibitors for NSCLC Industry Impact
1.6.1 How the Covid-19 is Affecting the Targeted Drug BRAF Inhibitors for NSCLC Industry
1.6.1.1 Targeted Drug BRAF Inhibitors for NSCLC Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Targeted Drug BRAF Inhibitors for NSCLC Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Targeted Drug BRAF Inhibitors for NSCLC Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Targeted Drug BRAF Inhibitors for NSCLC Market Perspective (2015-2026)
2.2 Targeted Drug BRAF Inhibitors for NSCLC Growth Trends by Regions
2.2.1 Targeted Drug BRAF Inhibitors for NSCLC Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Targeted Drug BRAF Inhibitors for NSCLC Historic Market Share by Regions (2015-2020)
2.2.3 Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Targeted Drug BRAF Inhibitors for NSCLC Market Growth Strategy
2.3.6 Primary Interviews with Key Targeted Drug BRAF Inhibitors for NSCLC Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Market Size
3.1.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Revenue (2015-2020)
3.1.2 Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Players (2015-2020)
3.1.3 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio
3.2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Targeted Drug BRAF Inhibitors for NSCLC Revenue in 2019
3.3 Targeted Drug BRAF Inhibitors for NSCLC Key Players Head office and Area Served
3.4 Key Players Targeted Drug BRAF Inhibitors for NSCLC Product Solution and Service
3.5 Date of Enter into Targeted Drug BRAF Inhibitors for NSCLC Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Historic Market Size by Type (2015-2020)
4.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Type (2021-2026)
5 TARGETED DRUG BRAF INHIBITORS FOR NSCLC BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
5.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
6.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in North America (2019-2020)
6.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
6.4 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
7.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in Europe (2019-2020)
7.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
7.4 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
8 CHINA
8.1 China Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
8.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in China (2019-2020)
8.3 China Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
8.4 China Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
9.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in Japan (2019-2020)
9.3 Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
9.4 Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
10.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
10.4 Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
11 INDIA
11.1 India Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
11.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in India (2019-2020)
11.3 India Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
11.4 India Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
12.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in Central & South America (2019-2020)
12.3 Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
12.4 Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 BeiGene
13.1.1 BeiGene Company Details
13.1.2 BeiGene Business Overview and Its Total Revenue
13.1.3 BeiGene Targeted Drug BRAF Inhibitors for NSCLC Introduction
13.1.4 BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020))
13.1.5 BeiGene Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Targeted Drug BRAF Inhibitors for NSCLC Introduction
13.2.4 Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020)
13.2.5 Novartis Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Targeted Drug BRAF Inhibitors for NSCLC Revenue
1.4 Market Analysis by Type
1.4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Dabrafenib
1.4.3 Trametinib
1.4.4 Lifirafenib
1.4.5 Other
1.5 Market by Application
1.5.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application: 2020 VS 2026
1.5.2 Squamous Cell Carcinoma of NSCLC
1.5.3 Adenocarcinoma of NSCLC
1.5.4 Large Cell Carcinoma of NSCLC
1.6 Coronavirus Disease 2019 (Covid-19): Targeted Drug BRAF Inhibitors for NSCLC Industry Impact
1.6.1 How the Covid-19 is Affecting the Targeted Drug BRAF Inhibitors for NSCLC Industry
1.6.1.1 Targeted Drug BRAF Inhibitors for NSCLC Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Targeted Drug BRAF Inhibitors for NSCLC Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Targeted Drug BRAF Inhibitors for NSCLC Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Targeted Drug BRAF Inhibitors for NSCLC Market Perspective (2015-2026)
2.2 Targeted Drug BRAF Inhibitors for NSCLC Growth Trends by Regions
2.2.1 Targeted Drug BRAF Inhibitors for NSCLC Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Targeted Drug BRAF Inhibitors for NSCLC Historic Market Share by Regions (2015-2020)
2.2.3 Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Targeted Drug BRAF Inhibitors for NSCLC Market Growth Strategy
2.3.6 Primary Interviews with Key Targeted Drug BRAF Inhibitors for NSCLC Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Market Size
3.1.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Revenue (2015-2020)
3.1.2 Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Players (2015-2020)
3.1.3 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio
3.2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Targeted Drug BRAF Inhibitors for NSCLC Revenue in 2019
3.3 Targeted Drug BRAF Inhibitors for NSCLC Key Players Head office and Area Served
3.4 Key Players Targeted Drug BRAF Inhibitors for NSCLC Product Solution and Service
3.5 Date of Enter into Targeted Drug BRAF Inhibitors for NSCLC Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Historic Market Size by Type (2015-2020)
4.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Type (2021-2026)
5 TARGETED DRUG BRAF INHIBITORS FOR NSCLC BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
5.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
6.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in North America (2019-2020)
6.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
6.4 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
7.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in Europe (2019-2020)
7.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
7.4 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
8 CHINA
8.1 China Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
8.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in China (2019-2020)
8.3 China Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
8.4 China Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
9.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in Japan (2019-2020)
9.3 Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
9.4 Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
10.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
10.4 Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
11 INDIA
11.1 India Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
11.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in India (2019-2020)
11.3 India Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
11.4 India Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2015-2020)
12.2 Targeted Drug BRAF Inhibitors for NSCLC Key Players in Central & South America (2019-2020)
12.3 Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020)
12.4 Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 BeiGene
13.1.1 BeiGene Company Details
13.1.2 BeiGene Business Overview and Its Total Revenue
13.1.3 BeiGene Targeted Drug BRAF Inhibitors for NSCLC Introduction
13.1.4 BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020))
13.1.5 BeiGene Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Targeted Drug BRAF Inhibitors for NSCLC Introduction
13.2.4 Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020)
13.2.5 Novartis Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Targeted Drug BRAF Inhibitors for NSCLC Key Market Segments
Table 2. Key Players Covered: Ranking by Targeted Drug BRAF Inhibitors for NSCLC Revenue
Table 3. Ranking of Global Top Targeted Drug BRAF Inhibitors for NSCLC Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Dabrafenib
Table 6. Key Players of Trametinib
Table 7. Key Players of Lifirafenib
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Targeted Drug BRAF Inhibitors for NSCLC Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Targeted Drug BRAF Inhibitors for NSCLC Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Targeted Drug BRAF Inhibitors for NSCLC Players to Combat Covid-19 Impact
Table 14. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Regions (2015-2020)
Table 18. Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Targeted Drug BRAF Inhibitors for NSCLC Market Growth Strategy
Table 24. Main Points Interviewed from Key Targeted Drug BRAF Inhibitors for NSCLC Players
Table 25. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue by Players (2015-2020) (Million US$)
Table 26. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Players (2015-2020)
Table 27. Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug BRAF Inhibitors for NSCLC as of 2019)
Table 28. Global Targeted Drug BRAF Inhibitors for NSCLC by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Targeted Drug BRAF Inhibitors for NSCLC Product Solution and Service
Table 31. Date of Enter into Targeted Drug BRAF Inhibitors for NSCLC Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 34. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Type (2015-2020)
Table 35. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Type (2021-2026)
Table 36. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Application (2015-2020)
Table 37. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 38. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Application (2021-2026)
Table 39. North America Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 41. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 42. North America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 43. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 44. North America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 45. Europe Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 47. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 49. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 51. China Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 52. China Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 53. China Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 54. China Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 55. China Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 56. China Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 57. Japan Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 59. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 61. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 65. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 67. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 69. India Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 70. India Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 71. India Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 72. India Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 73. India Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 74. India Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 77. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 79. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 81. BeiGene Company Details
Table 82. BeiGene Business Overview
Table 83. BeiGene Product
Table 84. BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 85. BeiGene Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 1. Targeted Drug BRAF Inhibitors for NSCLC Key Market Segments
Table 2. Key Players Covered: Ranking by Targeted Drug BRAF Inhibitors for NSCLC Revenue
Table 3. Ranking of Global Top Targeted Drug BRAF Inhibitors for NSCLC Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Dabrafenib
Table 6. Key Players of Trametinib
Table 7. Key Players of Lifirafenib
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Targeted Drug BRAF Inhibitors for NSCLC Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Targeted Drug BRAF Inhibitors for NSCLC Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Targeted Drug BRAF Inhibitors for NSCLC Players to Combat Covid-19 Impact
Table 14. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Regions (2015-2020)
Table 18. Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Targeted Drug BRAF Inhibitors for NSCLC Market Growth Strategy
Table 24. Main Points Interviewed from Key Targeted Drug BRAF Inhibitors for NSCLC Players
Table 25. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue by Players (2015-2020) (Million US$)
Table 26. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Players (2015-2020)
Table 27. Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug BRAF Inhibitors for NSCLC as of 2019)
Table 28. Global Targeted Drug BRAF Inhibitors for NSCLC by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Targeted Drug BRAF Inhibitors for NSCLC Product Solution and Service
Table 31. Date of Enter into Targeted Drug BRAF Inhibitors for NSCLC Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 34. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Type (2015-2020)
Table 35. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Type (2021-2026)
Table 36. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Application (2015-2020)
Table 37. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 38. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Application (2021-2026)
Table 39. North America Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 41. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 42. North America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 43. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 44. North America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 45. Europe Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 47. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 49. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 51. China Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 52. China Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 53. China Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 54. China Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 55. China Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 56. China Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 57. Japan Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 59. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 61. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 65. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 67. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 69. India Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 70. India Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 71. India Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 72. India Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 73. India Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 74. India Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Targeted Drug BRAF Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Targeted Drug BRAF Inhibitors for NSCLC Market Share (2019-2020)
Table 77. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 79. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 81. BeiGene Company Details
Table 82. BeiGene Business Overview
Table 83. BeiGene Product
Table 84. BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 85. BeiGene Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type: 2020 VS 2026
Figure 2. Dabrafenib Features
Figure 3. Trametinib Features
Figure 4. Lifirafenib Features
Figure 5. Other Features
Figure 6. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application: 2020 VS 2026
Figure 7. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 8. Adenocarcinoma of NSCLC Case Studies
Figure 9. Large Cell Carcinoma of NSCLC Case Studies
Figure 10. Targeted Drug BRAF Inhibitors for NSCLC Report Years Considered
Figure 11. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Regions: 2020 VS 2026
Figure 13. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Players in 2019
Figure 16. Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug BRAF Inhibitors for NSCLC as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Targeted Drug BRAF Inhibitors for NSCLC Revenue in 2019
Figure 18. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. BeiGene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. BeiGene Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020)
Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
Figure 1. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type: 2020 VS 2026
Figure 2. Dabrafenib Features
Figure 3. Trametinib Features
Figure 4. Lifirafenib Features
Figure 5. Other Features
Figure 6. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application: 2020 VS 2026
Figure 7. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 8. Adenocarcinoma of NSCLC Case Studies
Figure 9. Large Cell Carcinoma of NSCLC Case Studies
Figure 10. Targeted Drug BRAF Inhibitors for NSCLC Report Years Considered
Figure 11. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Regions: 2020 VS 2026
Figure 13. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Players in 2019
Figure 16. Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug BRAF Inhibitors for NSCLC as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Targeted Drug BRAF Inhibitors for NSCLC Revenue in 2019
Figure 18. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. BeiGene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. BeiGene Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020)
Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2015-2020)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed